• 1. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745
• 2. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 3. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459
• 4. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 5. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Quinolines and derivatives Haloquinolines

Comprehensive Overview of 4,7-Dibromoquinoline (CAS No. 700871-88-1): Properties, Applications, and Industry Insights

4,7-Dibromoquinoline (CAS No. 700871-88-1) is a halogenated quinoline derivative that has garnered significant attention in pharmaceutical and materials science research. This compound, characterized by two bromine atoms at the 4 and 7 positions of the quinoline ring, serves as a versatile intermediate in organic synthesis. Its molecular formula, C₉H₅Br₂N, and unique structural features make it valuable for constructing complex molecules, particularly in the development of fluorescent probes, pharmaceutical intermediates, and organic electronic materials.

The growing demand for 4,7-Dibromoquinoline is closely tied to its role in cross-coupling reactions, such as Suzuki-Miyaura and Buchwald-Hartwig couplings, which are pivotal in modern drug discovery. Researchers frequently search for "4,7-Dibromoquinoline synthesis" or "CAS 700871-88-1 applications" to explore its utility in creating heterocyclic compounds with potential biological activity. Recent studies highlight its use in designing anticancer agents and antimicrobial scaffolds, aligning with the global focus on novel therapeutics.

From a materials science perspective, 4,7-Dibromoquinoline contributes to advancements in organic light-emitting diodes (OLEDs) and photovoltaic cells. Its bromine substituents facilitate precise molecular engineering, addressing the industry's need for high-efficiency emitters. Queries like "quinoline derivatives for OLEDs" or "700871-88-1 solubility" reflect user interest in optimizing its performance in thin-film technologies.

Analytical data for CAS No. 700871-88-1 reveals a melting point range of 150–152°C and stability under inert conditions, making it suitable for high-temperature applications. Laboratories often inquire about "4,7-Dibromoquinoline purification methods" or "NMR spectra interpretation" to ensure reproducibility in synthetic protocols. The compound’s chromatographic behavior and spectroscopic fingerprints are well-documented, aiding quality control in commercial production.

Environmental and regulatory considerations for 4,7-Dibromoquinoline emphasize green chemistry principles. Innovations in catalyst-free reactions and solvent recovery systems address sustainability concerns, resonating with searches for "eco-friendly quinoline synthesis." Its low acute toxicity profile (as per available data) supports its adoption in industrial-scale processes.

Market trends indicate rising procurement of 700871-88-1 by contract research organizations (CROs) and academic institutions, driven by its cost-effectiveness compared to analogous iodinated quinolines. FAQs such as "4,7-Dibromoquinoline vs. 2,4-dibromoquinoline reactivity" underscore the need for comparative analyses in selective functionalization strategies.

In summary, 4,7-Dibromoquinoline (CAS No. 700871-88-1) bridges multiple scientific disciplines, offering solutions for drug development, advanced materials, and sustainable chemistry. Its well-defined properties and adaptability to diverse reaction conditions position it as a cornerstone in contemporary organic synthesis.

• 3964-04-3(4-Bromoquinoline)
• 4964-71-0(5-Bromoquinoline)
• 34522-69-5(5,7-Dibromoquinoline)
• 52488-36-5(4-Bromo-1H-indole)
• 4965-36-0(7-Bromoquinoline)
• 30727-61-8(6-Bromobenzo[h]quinoline)
• 5268-14-4(4-Bromo-1,6-naphthyridine)
• 152583-10-3(Benzo[h]quinoline, 10-bromo-)
• 927801-13-6(4,6-Dibromoquinoline)
• 421580-26-9(5-Bromoquinoline hydrochloride)